Skip to main content

Table 5 Effect of low and high doses of metal nanocomposite on iron (Fe), copper (Cu) and zinc (Zn) residues in liver and muscle (Mean ± SE) n = 5

From: The efficacy of metal nanocomposite (Fe3O4/CuO/ZnO) to ameliorate the toxic effects of ochratoxin in broilers

 

G

Liver

Muscle

Fe (μg/ml)

Cu (μg/ml)

Zn (μg/ml)

Fe (μg/ml)

Cu (μg/ml)

Zn (μg/ml)

After treatment

1

22.96 ± 0.35c

1.50 ± 0.01a

8.07 ± 0.10a

11.92 ± 0.24d

0.73 ± 0.01a

8.54 ± 0.11c

2

16.86 ± 0.33a

5.11 ± 0.08d

12.40 ± 0.18c

14.46 ± 0.20e

0.54 ± 0.01a

6.98 ± 0.08b

3

20.75 ± 0.28b

2.29 ± 0.03b

9.96 ± 0.17b

5.62 ± 0.07b

0.60 ± 0.01a

6.09 ± 0.28a

4

42.17 ± 0.54e

3.13 ± 0.04c

14.63 ± 0.21d

8.35 ± 0.11c

0.97 ± 0.01b

7.14 ± 0.08b

5

15.91 ± 0.25a

2.19 ± 0.02b

8.64 ± 0.25a

4.33 ± 0.07a

0.68 ± 0.02a

5.70 ± 0.16a

6

33.24 ± 0.43d

2.26 ± 0.04b

9.78 ± 0.23b

8.44 ± 0.08c

1.26 ± 0.14c

6.09 ± 0.13a

At the end of experiment

1

22.03 ± 0.17de

1.50 ± 0.02c

7.84 ± 0.10c

11.08 ± 0.15e

0.61 ± 0.01d

7.80 ± 0.08e

2

16.76 ± 0.14b

4.24 ± 0.15d

11.39 ± 0.18d

13.52 ± 0.25f

0.43 ± 0.01c

5.85 ± 0.10c

3

13.74 ± 0.30a

0.74 ± 0.01b

5.82 ± 0.04b

3.54 ± 0.08a

0.12 ± 0.01a

3.72 ± 0.01a

4

21.48 ± 0.49d

1.50 ± 0.01c

14.41 ± 0.24e

8.46 ± 0.13d

0.15 ± 0.00b

7.41 ± 0.12d

5

20.19 ± 0.33c

0.09 ± 0.00a

3.34 ± 0.14a

6.44 ± 0.15b

0.11 ± 0.00a

4.11 ± 0.08b

6

22.84 ± 0.46e

0.85 ± 0.01b

8.20 ± 0.12c

7.40 ± 0.18c

0.17 ± 0.00b

4.32 ± 0.04b

  1. The various letters in the same column of the same period indicate statistically significant differences when (P < 0.05)
  2. G1 = OTA free control, G2 = OTA fed positive control, G3 = OTA free (low dose), G4 = OTA free (high dose), G5 = OTA treated (low dose), G6 = OTA treated (high dose)